Incyte | Aktuelle Verpflichtungen

Current Liabilities Veränderung Datum
Acadia Pharmaceuticals USD 254.25M 44.65M 2023-12
Agios Pharmaceuticals USD 67.96M 9.53M 2023-12
Alnylam Pharmaceuticals USD 967.79M 18M 2023-12
Amgen USD 18.39B 1.44B 2023-12
Bristol-Myers Squibb USD 23.46B 3.31B 2023-09
Eli Lilly USD 22B 3.08B 2023-09
Exelixis USD 376.82M 37.2M 2023-09
Gilead Sciences USD 11.28B 665M 2023-12
Incyte USD 1.24B 115.7M 2023-12
Ionis Pharmaceuticals USD 448.09M 43.88M 2023-12
Merck USD 23.09B 300M 2023-09
Moderna USD 3.02B 1.37B 2023-12
Neurocrine Biosciences USD 691.6M 109.1M 2023-09
Pfizer USD 31.14B 3.51B 2023-09
PTC Therapeutics USD 603.1M 110.98M 2023-12
Regeneron Pharmaceuticals USD 4.4B 805.6M 2023-12
Sarepta Therapeutics USD 450.74M 47.91M 2023-09
Ultragenyx Pharmaceutical USD 253.98M 9.6M 2023-09
Vertex Pharmaceuticals USD 3.6B 247.3M 2023-09



Incyte Aktuelle Verpflichtungen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2024.